Sandra Gardiner
Chief Financial Officer
@
Nektar Therapeutics
About Sandra Gardiner
Sandra Gardiner is a seasoned business and finance executive with over 30 years of experience, currently serving as CFO and Partner at FLG Partners and previously holding multiple CFO roles in global companies.
Known information
Sandra Gardiner is a distinguished Chief Financial Officer and Partner at FLG Partners, a prominent CFO services firm based in Silicon Valley. With a career spanning over three decades, she has developed extensive expertise in the Life Sciences sector. Since November 2019, Gardiner has been the Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary, and Treasurer at Pulse Biosciences, Inc. Her experience includes serving in CFO roles for various domestic and international companies, directing subsidiaries across Europe, Asia Pacific, and Latin America. Gardiner has played a pivotal role in executing numerous significant financial transactions, such as IPOs, secondary offerings, private placements, reverse mergers, rights offerings, ATMs, and debt facilities, collectively raising over $1 billion in capital. Additionally, she has successfully completed two mergers and acquisitions transactions, further showcasing her proficiency in financial management and corporate strategy.
About Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company focused on developing novel therapies that modulate the immune system to treat autoimmune disorders, chronic inflammatory conditions, and cancer.